FCR Regimen - CISMeF

Preferred Label : FCR Regimen;

NCIt synonyms : Cyclophosphamide-Fludarabine-Rituximab Regimen; Cyclophosphamide/Fludarabine/Rituximab Regimen; Cyclophosphamide/Fludarabine/Rituximab; Cyclophosphamide-Fludarabine-Rituximab;

NCIt related terms : R-FCM; FCR; FCR (rituximab-blit); FCR (rituximab-rite); FCR (rituximab-rixi); FCR (rituximab-rixa); FCR (rituximab-abbs); FCR (rituximab-pvvr); FCR (rituximab-arrx);

NCIt definition : A regimen consisting of fludarabine, cyclophosphamide and rituximab that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma.;

NCIt note : Source: PDQ;

Codes from synonyms : 2937; 127869; 128654; 128497; 128026; 127712; 128183; 128340;

Details

Origin ID

C63755;

UMLS CUI

C1880650;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Fludarabine [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]
regimen_has_accepted_use_for_disease
- Chronic Lymphocytic Leukemia [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients